Annual ROE
468.15%
+795.96%+242.81%
December 31, 2023
Summary
- As of February 8, 2025, SLS annual return on equity is 468.15%, with the most recent change of +795.96% (+242.81%) on December 31, 2023.
- During the last 3 years, SLS annual ROE has risen by +566.56% (+575.71%).
- SLS annual ROE is now at all-time high.
Performance
SLS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-629.45%
+16.72 K%+96.37%
September 30, 2024
Summary
- As of February 8, 2025, SLS quarterly return on equity is -629.45%, with the most recent change of +16.72 thousand% (+96.37%) on September 30, 2024.
- Over the past year, SLS quarterly ROE has increased by +1776.09% (+73.83%).
- SLS quarterly ROE is now -1615.12% below its all-time high of -36.70%, reached on March 31, 2017.
Performance
SLS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SLS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +242.8% | +73.8% |
| 3 y3 years | +575.7% | -54.7% |
| 5 y5 years | +188.7% | -54.7% |
SLS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +242.8% | -733.7% | +96.4% |
| 5 y | 5-year | at high | +242.8% | -781.0% | +96.4% |
| alltime | all time | at high | +100.4% | -1615.1% | +99.8% |
SELLAS Life Sciences ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -629.45%(-96.4%) |
| Jun 2024 | - | -17.35 K%(+229.9%) |
| Mar 2024 | - | -5258.30%(+118.6%) |
| Dec 2023 | 468.15%(-242.8%) | -2405.54%(+198.7%) |
| Sep 2023 | - | -805.32%(+97.9%) |
| Jun 2023 | - | -406.99%(+41.8%) |
| Mar 2023 | - | -287.10%(-29.6%) |
| Dec 2022 | -327.81%(+282.5%) | -407.61%(+47.2%) |
| Sep 2022 | - | -276.86%(+24.8%) |
| Jun 2022 | - | -221.83%(+43.2%) |
| Mar 2022 | - | -154.86%(+105.1%) |
| Dec 2021 | -85.70%(-12.9%) | -75.50%(+5.7%) |
| Sep 2021 | - | -71.45%(-4.3%) |
| Jun 2021 | - | -74.64%(-24.0%) |
| Mar 2021 | - | -98.16%(-36.9%) |
| Dec 2020 | -98.41%(-68.9%) | -155.60%(-44.4%) |
| Sep 2020 | - | -280.10%(+19.1%) |
| Jun 2020 | - | -235.23%(+4.8%) |
| Mar 2020 | - | -224.55%(-8.6%) |
| Dec 2019 | -316.63%(-40.0%) | -245.68%(+0.7%) |
| Sep 2019 | - | -244.02%(-11.7%) |
| Jun 2019 | - | -276.37%(-47.8%) |
| Mar 2019 | - | -529.78%(-15.9%) |
| Dec 2018 | -527.55%(-54.0%) | -629.69%(+231.8%) |
| Sep 2018 | - | -189.78%(-31.3%) |
| Jun 2018 | - | -276.11%(+94.3%) |
| Mar 2018 | - | -142.12%(+16.6%) |
| Dec 2017 | -1147.54%(-424.3%) | -121.89%(+19.9%) |
| Sep 2017 | - | -101.62%(+1.8%) |
| Jun 2017 | - | -99.86%(+172.1%) |
| Mar 2017 | - | -36.70%(-72.9%) |
| Dec 2016 | 353.83%(-174.8%) | -135.63%(-26.2%) |
| Sep 2016 | - | -183.79%(-3.6%) |
| Jun 2016 | - | -190.61%(-9.0%) |
| Mar 2016 | - | -209.41%(+25.5%) |
| Dec 2015 | -472.89% | -166.90%(+33.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | -124.96%(+26.9%) |
| Jun 2015 | - | -98.51%(-10.9%) |
| Mar 2015 | - | -110.51%(-10.3%) |
| Dec 2014 | -98.78%(-92.4%) | -123.15%(-53.3%) |
| Sep 2014 | - | -263.89%(-14.2%) |
| Jun 2014 | - | -307.41%(+12.4%) |
| Mar 2014 | - | -273.55%(-29.5%) |
| Dec 2013 | -1302.72%(+934.0%) | -388.00%(+206.6%) |
| Sep 2013 | - | -126.55%(-11.9%) |
| Jun 2013 | - | -143.68%(+55.4%) |
| Mar 2013 | - | -92.48%(-66.6%) |
| Dec 2012 | -125.99%(+10.9%) | -277.16%(-23.2%) |
| Sep 2012 | - | -361.08%(-26.9%) |
| Jun 2012 | - | -493.74%(-46.2%) |
| Mar 2012 | - | -918.46%(+458.2%) |
| Dec 2011 | -113.58%(-77.0%) | -164.53%(-44.2%) |
| Sep 2011 | - | -294.63%(+2.2%) |
| Jun 2011 | - | -288.39%(-7.2%) |
| Mar 2011 | - | -310.64%(+23.5%) |
| Dec 2010 | -493.54%(-80.1%) | -251.62%(-33.0%) |
| Sep 2010 | - | -375.46%(+22.7%) |
| Jun 2010 | - | -305.89%(-29.8%) |
| Mar 2010 | - | -435.83%(-4.2%) |
| Dec 2009 | -2481.38%(+1448.2%) | -454.73%(+70.8%) |
| Sep 2009 | - | -266.22%(+23.2%) |
| Jun 2009 | - | -216.01%(+42.4%) |
| Mar 2009 | - | -151.64%(+16.8%) |
| Dec 2008 | -160.27%(+57.8%) | -129.86%(+15.2%) |
| Sep 2008 | - | -112.69%(+11.5%) |
| Jun 2008 | - | -101.10%(-10.9%) |
| Mar 2008 | - | -113.50%(+21.4%) |
| Dec 2007 | -101.54%(-99.9%) | -93.51%(-35.1%) |
| Sep 2007 | - | -144.01%(-100.0%) |
| Jun 2007 | - | -346.85 K%(+218.5%) |
| Mar 2007 | - | -108.90 K%(+184.3%) |
| Dec 2006 | -120.25 K% | -38.30 K% |
FAQ
- What is SELLAS Life Sciences annual return on equity?
- What is the all time high annual ROE for SELLAS Life Sciences?
- What is SELLAS Life Sciences annual ROE year-on-year change?
- What is SELLAS Life Sciences quarterly return on equity?
- What is the all time high quarterly ROE for SELLAS Life Sciences?
- What is SELLAS Life Sciences quarterly ROE year-on-year change?
What is SELLAS Life Sciences annual return on equity?
The current annual ROE of SLS is 468.15%
What is the all time high annual ROE for SELLAS Life Sciences?
SELLAS Life Sciences all-time high annual return on equity is 468.15%
What is SELLAS Life Sciences annual ROE year-on-year change?
Over the past year, SLS annual return on equity has changed by +795.96% (+242.81%)
What is SELLAS Life Sciences quarterly return on equity?
The current quarterly ROE of SLS is -629.45%
What is the all time high quarterly ROE for SELLAS Life Sciences?
SELLAS Life Sciences all-time high quarterly return on equity is -36.70%
What is SELLAS Life Sciences quarterly ROE year-on-year change?
Over the past year, SLS quarterly return on equity has changed by +1776.09% (+73.83%)